Rory Care

1.7k total citations
14 papers, 1.2k citations indexed

About

Rory Care is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rory Care has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Microbiology, 7 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Rory Care's work include Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (5 papers) and Acute Myeloid Leukemia Research (3 papers). Rory Care is often cited by papers focused on Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (5 papers) and Acute Myeloid Leukemia Research (3 papers). Rory Care collaborates with scholars based in United Kingdom, Netherlands and Norway. Rory Care's co-authors include Anne Goodeve, I. R. Peake, G. A. Wilson, Peter E. Sudbery, Katie Binley, Ian M. Feavers, John T. Reilly, Mamdooh Gari, Faisel M. Abuduhier and Peter J.M. Valk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Microbiology.

In The Last Decade

Rory Care

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rory Care United Kingdom 10 497 459 377 317 239 14 1.2k
Federica Andreoni Switzerland 14 269 0.5× 281 0.6× 119 0.3× 122 0.4× 199 0.8× 33 932
Jacinto López‐Sagaseta Spain 16 142 0.3× 282 0.6× 137 0.4× 47 0.1× 63 0.3× 25 1.0k
Harald Seeberger Germany 10 154 0.3× 125 0.3× 67 0.2× 58 0.2× 76 0.3× 13 633
Brice Lagrange France 14 95 0.2× 822 1.8× 131 0.3× 57 0.2× 28 0.1× 20 1.1k
Richard Stillion United Kingdom 7 124 0.2× 205 0.4× 85 0.2× 30 0.1× 83 0.3× 9 714
Nilanjana Banerji United States 13 78 0.2× 237 0.5× 362 1.0× 28 0.1× 53 0.2× 20 743
C H Hammer United States 12 120 0.2× 135 0.3× 173 0.5× 52 0.2× 33 0.1× 14 703
Pramod Giri United States 11 51 0.1× 348 0.8× 180 0.5× 65 0.2× 23 0.1× 14 679
Brigitte Lemercier France 16 34 0.1× 276 0.6× 99 0.3× 116 0.4× 68 0.3× 21 952
Susan H. Turner United States 13 26 0.1× 144 0.3× 428 1.1× 155 0.5× 46 0.2× 17 680

Countries citing papers authored by Rory Care

Since Specialization
Citations

This map shows the geographic impact of Rory Care's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory Care with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory Care more than expected).

Fields of papers citing papers by Rory Care

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rory Care. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory Care. The network helps show where Rory Care may publish in the future.

Co-authorship network of co-authors of Rory Care

This figure shows the co-authorship network connecting the top 25 collaborators of Rory Care. A scholar is included among the top collaborators of Rory Care based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rory Care. Rory Care is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Care, Rory, Peter Rigsby, Kevin Markey, et al.. (2023). Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines. Vaccine. 41(38). 5603–5613. 1 indexed citations
2.
Vipond, Caroline, et al.. (2018). Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine. Vaccine. 37(29). 3747–3753. 11 indexed citations
3.
Sutherland, Janet, et al.. (2018). Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study. Vaccine. 37(29). 3761–3769. 12 indexed citations
4.
Care, Rory, et al.. (2015). Sinonasal Lymphoma Presenting as a Probable Sanctuary Site for Relapsed B Acute Lymphoblastic Leukaemia: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2015. 1–5. 1 indexed citations
5.
Norheim, Gunnstein, Holly Sanders, Hannah Chan, et al.. (2015). An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity. PLoS ONE. 10(9). e0134353–e0134353. 8 indexed citations
6.
Maharjan, Sunil, Muhammad Saleem, Ian M. Feavers, et al.. (2015). Dissection of the function of the RmpM periplasmic protein from Neisseria meningitidis. Microbiology. 162(2). 364–375. 22 indexed citations
7.
Chan, Hannah, Neil J. Oldfield, Xilian Bai, et al.. (2014). Phase Variation Mediates Reductions in Expression of Surface Proteins during Persistent Meningococcal Carriage. Infection and Immunity. 82(6). 2472–2484. 34 indexed citations
8.
Harrison, Odile B., Heike Claus, Ying Jiang, et al.. (2013). Description and Nomenclature ofNeisseria meningitidisCapsule Locus. Emerging infectious diseases. 19(4). 566–573. 229 indexed citations
9.
Vipond, Caroline, Rory Care, & Ian M. Feavers. (2012). History of meningococcal vaccines and their serological correlates of protection. Vaccine. 30. B10–B17. 55 indexed citations
11.
Care, Rory, Peter J.M. Valk, Anne Goodeve, et al.. (2003). Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. British Journal of Haematology. 121(5). 775–777. 231 indexed citations
12.
Abuduhier, Faisel M., Anne Goodeve, Rory Care, et al.. (2003). Mutational analysis of class III receptor tyrosine kinases (C‐KIT, C‐FMS, FLT3) in idiopathic myelofibrosis. British Journal of Haematology. 120(3). 464–470. 26 indexed citations
13.
Goodeve, Anne, et al.. (2001). Identification of novel FLT‐3 Asp835 mutations in adult acute myeloid leukaemia. British Journal of Haematology. 113(4). 983–988. 305 indexed citations
14.
Care, Rory, et al.. (1999). The MET3 promoter: a new tool for Candida albicans molecular genetics. Molecular Microbiology. 34(4). 792–798. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026